IMAX China valuation higher than initially thought, says MKM Partners After reevaluating IMAX's sale of a minority interest in IMAX China last month, MKM Partners now believes that IMAX China is being valued at a premium closer to 4-5 turns higher than the company's overall valuation, versus earlier estimates of in-line to just under a 1-turn premium. The firm now thinks the company may spin off the subsidiary in an IPO within the next 24-36 months. It keeps a $36 price target and Buy rating on the shares.
IMAX a Top Idea for 2015 at MKM Partners MKM Partners named IMAX a Top Idea for 2015 and expects it to be a breakout year for the company due to a strong film slate, expanding China presence, and cost containment that will drive revenue growth and margin expansion. Shares are Buy rate with an increased price target of $36 from $34.